Searched for
OPHTHALMIC FORMULATION
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
- Speciality Medicines IPO: SME stock to list today. Check price band, other detailsSpeciality Medicines shares debut on the BSE SME platform today. The company's IPO, a fresh issue, sought to raise approximately Rs 29 cror...
- Are your eye drops safe? CDSCO flags illegal products, doctors issue strong warning on irritation, conjunctivitisAuthorities have launched a major crackdown on unapproved dry eye relief drops being sold without mandatory CDSCO approval. States and Unio...
- Cipla partners with CSIR-CDRI to develop formulation for fungal keratitisDrug major Cipla on Thursday said it has tied up with CSIR-Central Drug Research Institute to jointly develop a novel ophthalmic formulatio...
- Fundamental Radar: Why risk-reward in Lupin remains favourable even after 80% run-up?The company’s US business was adversely impacted by regulatory issues. However, with clearance for the formulation sites, the product pipel...
- InvAscent picks minority stake in domestic ophthalmic formulation firm Sunways for Rs 120 croreFounded in 1951 by Kantilal Shroff, the Mumbai-headquartered Sunways is a leading domestic manufacturer and marketer of ophthalmic formulat...
- Indoco in talks to sell part of India operationsIndoco’s domestic formulations sales for the year ended March 31, 2018, were flat at Rs 595 crore, as against Rs 585 crore last year (growt...
- Aurobindo Pharma gets USFDA nod for anaesthesia drugQuoting IQVIA data, Aurobindo Pharma said the approved product has an estimated market size of USD 11 million for the 12 months ending Sept...
- Local pharma formulators to benefit from new USFDA generic guidance: ReportThis will help domestic pharma formulators with pending ANDA approvals to reduce review cycles and expedite approvals, says a weekend repor...
- Sun Pharma climbs 3% after USFDA accepts new drug applicationhares of the company opened at Rs 545 and touched a high and low of Rs 559.30 and Rs 543.15, respectively, in trade so far.
- Aurobindo Pharma gets USFDA nod for Fondaparinux Sodium injectionThe approved ANDA is a bioequivalent and therapeutically equivalent to the reference listed drug product Arixtra Injection of Mylan Ireland...
- USFDA accepts Sun Pharma arm's ophthalmic drug applicationSun Pharma said that post the USFDA approval, OTX-101 will be commercialised in the US by Sun Ophthalmics, the branded ophthalmics division...
- Sun Pharma to buy Ocular Technologies from Auven TherapeuticsSun will pay Auven $40 million upfront, contingent development milestones and sales milestones, in addition to royalties on sales of Secier...
- Indian drug regulator backs off over use of Roche’s AvastinThe Drug Controller General of India has passed an order removing an alert notice for the use of Roche’s Avastin (bevacizumab) injection to...
- Indoco Remedies to invest Rs 125 crore for business expansionIndoco Remedies Ltd said it is looking at an investment of Rs 125 crore for expansion of its sterile ophthalmic facility at Goa and for set...
- Bal Pharma to raise $20 mn for expansionBangalore-based pharma company Bal Pharma is planning to raise $20 million for capacity expansion and asset acquisition.
- Indoco in JV to sell ophthalmic products in USIndoco Remedies has formalised a joint venture agreement with New Jersey-based Amneal Pharmaceuticals to market 10 ophthalmic products in t...
- Mankind Pharma to set up R&D units in HP, NCRPharmaceutical company, Mankind Pharma has said it will set up manufacturing and research facilities in Himachal Pradesh and National Capit...
Load More
